Urgent call to address antibiotic pipeline failure

The critical need to develop new antibiotics has been underlined by the Association of the British Pharmaceutical Industry (ABPI).

In an age when drug resistant microbes are developing faster than new antimicrobial treatments, the UK’s pharma trade association has issued a rallying call to governments, healthcare workers and pharma companies around the world to do more to avoid the threat posed by antibiotic resistance.

"Antibiotic resistance is a silent threat to the very foundations of modern medicine"They can do this by coming together to protect existing antimicrobial treatments and collaborate at a global level to develop sustainable long-term solutions for discovering new treatments and bringing these to patients, according to the ABPI.